Education
About Us
Working with TipRanks
Follow Us
bioMerieux (GB:0RUG)
LSE:0RUG
0RUG Analyst Ratings
Hold
0 Buy
5 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0RUG Stock 12 Month Forecast
Average Price Target
€107.80
▲(8.80% Upside)
| Highest Price Target€115.00 | Average Price Target€107.80 | Lowest Price Target€100.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Barclays
€110→€100
Hold
0.93%
Upside
Reiterated
02/24/26
Morgan Stanley
€112→€109
Hold
10.01%
Upside
Reiterated
02/02/26
Exane BNP Paribas
€100
Hold
0.93%
Upside
Downgraded
01/28/26
RBC Capital
€115
Hold
16.07%
Upside
Reiterated
01/23/26
Bank of America Securities
€90→€115
Hold
16.07%
Upside
Upgraded
12/12/25
UBS
€132→€138
Buy
39.28%
Upside
Reiterated
10/28/25
Kepler Capital
€140
Buy
41.30%
Upside
Reiterated
09/08/25
J.P. Morgan
€120.5
Hold
21.62%
Upside
Initiated
08/27/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Barclays
€110→€100
Hold
0.93%
Upside
Reiterated
02/24/26
Morgan Stanley
€112→€109
Hold
10.01%
Upside
Reiterated
02/02/26
Exane BNP Paribas
€100
Hold
0.93%
Upside
Downgraded
01/28/26
RBC Capital
€115
Hold
16.07%
Upside
Reiterated
01/23/26
Bank of America Securities
€90→€115
Hold
16.07%
Upside
Upgraded
12/12/25
UBS
€132→€138
Buy
39.28%
Upside
Reiterated
10/28/25
Kepler Capital
€140
Buy
41.30%
Upside
Reiterated
09/08/25
J.P. Morgan
€120.5
Hold
21.62%
Upside
Initiated
08/27/25
Best Analysts Covering bioMerieux
3 Months
xxx
Success Rate
18/32 ratings generated profit
Average Return
-0.48%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 56.25% of your transactions generating a profit, with an average return of -0.48% per trade.
1 Year
Success Rate
18/32 ratings generated profit
Average Return
+1.38%
reiterated a buy rating 6 months ago
Copying Maja Pataki's trades and holding each position for 1 Year would result in 56.25% of your transactions generating a profit, with an average return of +1.38% per trade.
2 Years
xxx
Success Rate
14/32 ratings generated profit
Average Return
+3.80%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 43.75% of your transactions generating a profit, with an average return of +3.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0RUG Analyst Recommendation Trends
Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
0
0
0
0
0
Buy
9
6
4
0
0
Hold
17
12
12
13
32
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
26
18
16
13
32
Each month's total comprises the sum of three months' worth of ratings.
0RUG Financial Forecast
0RUG Stock Forecast FAQ
What is GB:0RUG’s average 12-month price target, according to analysts?
Based on analyst ratings, bioMerieux’s 12-month average price target is 107.80.
What is GB:0RUG’s upside potential, based on the analysts’ average price target?
bioMerieux has 8.80% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is bioMerieux a Buy, Sell or Hold?
bioMerieux has a consensus rating of Hold, which is based on 0 buy ratings, 5 hold ratings and 0 sell ratings.
What is bioMerieux’s share price target?
The average share price target for bioMerieux is 107.80. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €115.00 ,and the lowest forecast is €100.00. The average share price target represents 8.80% Increase from the current price of €99.08.
The highest analyst share price target is €115.00 ,and the lowest forecast is €100.00. The average share price target represents 8.80% Increase from the current price of €99.08.
What do analysts say about bioMerieux?
bioMerieux’s analyst rating consensus is a Hold. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of bioMerieux?
To buy shares of GB:0RUG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.